Orion in Estonia
E-mail: firstname.lastname@orion.fi
Address:
-
Office Orion in Estonia
Orionintie 1A, FI-02200 Espoo; P.O.Box 65, FI-02101 Espoo
Phone: +358 10 4261
Clinical Trials sponsored by Orion
-
Orion Corporation, Orion PharmaCompletatoCancro al seno avanzato | Cancro al seno metastatico | Cancro alla prostata resistente alla castrazione | Cancro alla prostata metastaticoFinlandia, Francia, Danimarca
-
Orion Corporation, Orion PharmaCompletato
-
Orion Corporation, Orion PharmaCompletatoVolontari saniFinlandia
-
Orion Corporation, Orion PharmaCompletatoSclerosi laterale amiotroficaCanada, Stati Uniti, Australia, Austria, Regno Unito, Germania, Finlandia, Spagna, Francia, Italia, Svezia, Olanda, Belgio, Irlanda
-
Orion Corporation, Orion PharmaCompletato
-
Orion Corporation, Orion PharmaTerminato
-
Orion Corporation, Orion PharmaCompletatoMalattia del SNCFinlandia
-
Orion Corporation, Orion PharmaCompletatoVolontariato sano | BPCOEstonia
-
Orion Corporation, Orion PharmaCompletato
-
Orion Corporation, Orion PharmaCompletatoCancro alla prostataStati Uniti, Regno Unito, Finlandia, Francia, Estonia, Repubblica Ceca
About Orion
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organisation covers almost all key European markets and a few Southeast Asian countries.